NORTHBROOK, Ill., Nov. 10, 2008 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today reported financial results for the third quarter and nine months ended September 30, 2008 and announced the filing of FDA 510(k) submissions for two new assays.
